Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Loss

December 4, 2024/in Uncategorized /by

Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed the potential for wildly popular weight-loss drugs to be used to treat many other conditions.

Call for more information

888-531-0245

info@siii-clinical.com

From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.

Get More Information